Clinical Trials Browser

Phase 2/3 × Terminated × Carcinoma, Non-Small-Cell Lung × Clear all

Carcinoma, Non-Small-Cell Lung, Fatigue

NCT01774578 2020-05-28

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Phase 2/3 Terminated

135 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT02186301 2019-05-07

EGFR

Phase 2/3 Terminated

100 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT01208064 2018-07-12

Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy

Phase 2/3 Terminated

102 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02326285 2018-01-23

NeoIntercal

Phase 2/3 Terminated

1 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01319669 2017-03-03

Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy

Phase 2/3 Terminated

11 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01383148 2017-01-05

TIME

Phase 2/3 Terminated

222 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01348126 2015-11-05

GALAXY

Phase 2/3 Terminated

385 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01761747 2014-12-23

Ponatinib for Squamous Cell Lung and Head and Neck Cancers

Phase 2/3 Terminated

3 enrolled 9 charts

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00516685 2011-09-30

NSCLC

Phase 2/3 Terminated

230 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

EGFR

Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy

NeoIntercal

Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy

TIME

GALAXY

Ponatinib for Squamous Cell Lung and Head and Neck Cancers

NSCLC